The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
Authors
Keywords
-
Journal
Journal of Allergy and Clinical Immunology-In Practice
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-06-18
DOI
10.1016/j.jaip.2021.06.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
- (2021) Saborni Chakraborty et al. ADVANCED DRUG DELIVERY REVIEWS
- Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines
- (2021) Kevin R. Murphy et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
- (2021) Tom Shimabukuro et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
- (2021) Aleena Banerji et al. Journal of Allergy and Clinical Immunology-In Practice
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Acute Allergic Reactions to mRNA COVID-19 Vaccines
- (2021) Kimberly G. Blumenthal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
- (2021) Tom T. Shimabukuro et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety of new MRNA Vaccines Against COVID-19 in Severe Allergic Patients
- (2021) P Rojas-Pérez-Ezquerra et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
- (2021) Peter Richmond et al. LANCET
- Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients
- (2021) Sharon Amit et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination
- (2021) Siri R. Kadire et al. NEW ENGLAND JOURNAL OF MEDICINE
- A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine
- (2021) Laurence Chu et al. VACCINE
- COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
- (2021) Paul J. Turner et al. World Allergy Organization Journal
- Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions
- (2021) Mitchell M. Pitlick et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines
- (2021) John M. Kelso ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine
- (2021) Priya Sellaturay et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
- (2021) Kimberly A. Risma et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
- (2021) Aleena Banerji et al. Journal of Allergy and Clinical Immunology-In Practice
- Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine
- (2021) João Marcelino et al. Journal of Allergy and Clinical Immunology-In Practice
- Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2
- (2021) Vincenzo Restivo et al. Vaccines
- COVID-19—New Insights on a Rapidly Changing Epidemic
- (2020) Carlos del Rio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
- (2020) Marcus S. Shaker et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Diagnosing, managing and preventing anaphylaxis: Systematic review
- (2020) Debra de Silva et al. ALLERGY
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)
- (2020) Priya Sellaturay et al. Journal of Allergy and Clinical Immunology-In Practice
- ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper
- (2020) Ludger Klimek et al. ALLERGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maintaining Safety with SARS-CoV-2 Vaccines
- (2020) Mariana C. Castells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
- (2020) Zhao-Hua Zhou et al. Journal of Allergy and Clinical Immunology-In Practice
- Anaphylaxis After Vaccination Reported To The Vaccine Adverse Event Reporting System, 1990–2016
- (2019) John R. Su et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anaphylaxis due to macrogol in a laxative solution with a positive basophil activation test
- (2019) Nicola Giangrande et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge
- (2019) Yiwei Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Time to revisit the definition and clinical criteria for anaphylaxis?
- (2019) Paul J. Turner et al. World Allergy Organization Journal
- Administration of influenza vaccines to egg allergic recipients: A practice parameter update 2017
- (2018) Matthew Greenhawt et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- High volume of polysorbate-containing (Tween® 80) solutions induces false-positive results in intradermal test
- (2018) N. Wagner et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Anaphylaxis to trometamol excipient in gadolinium based contrast agents for clinical imaging.
- (2018) Joanna Lukawska et al. Journal of Allergy and Clinical Immunology-In Practice
- Antibiotic allergy
- (2018) Kimberly G Blumenthal et al. LANCET
- Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized
- (2018) Cosby A. Stone et al. Journal of Allergy and Clinical Immunology-In Practice
- Fatal Anaphylaxis: Mortality Rate and Risk Factors
- (2017) Paul J. Turner et al. Journal of Allergy and Clinical Immunology-In Practice
- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
- (2016) Qi Yang et al. ANALYTICAL CHEMISTRY
- Immediate-type hypersensitivity to polyethylene glycols: a review
- (2016) E. Wenande et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
- (2016) Victoria R Cornelius et al. BMJ Open
- International Consensus (ICON): allergic reactions to vaccines
- (2016) Stephen C. Dreskin et al. World Allergy Organization Journal
- Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
- (2015) Tom T. Shimabukuro et al. VACCINE
- Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy
- (2014) Stefano Pizzimenti et al. Journal of Allergy and Clinical Immunology-In Practice
- Case fatality and population mortality associated with anaphylaxis in the United States
- (2013) Larry Ma et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE
- (2012) Isabelle Rouleau et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adverse reactions to vaccines practice parameter 2012 update
- (2012) John M. Kelso et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hypersensitivity to Polyethylene Glycols
- (2012) Sapna Shah et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations
- (2011) J. L. Brożek et al. ALLERGY
- Macrogol hypersensitivity in multiple drug allergy
- (2011) Luisa Bommarito et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Biologic-induced urticaria due to polysorbate 80: usefulness of prick test
- (2011) L. Pérez-Pérez et al. BRITISH JOURNAL OF DERMATOLOGY
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine
- (2010) Remi Gagnon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies
- (2009) J. L. Brożek et al. ALLERGY
- Grading quality of evidence and strength of recommendations in clinical practice guidelines
- (2009) J. L. Brożek et al. ALLERGY
- Diagnostic Utility of Two Case Definitions for Anaphylaxis
- (2009) Michel Erlewyn-Lajeunesse et al. DRUG SAFETY
- Patient-Centered Care and Preference-Sensitive Decision Making
- (2009) Carla C. Keirns JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immediate allergic reactions by polyethylene glycol 4000: two cases
- (2008) M. Antón Gironés et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Usefulness of oral macrogol challenge in anaphylaxis after intra-articular injection of corticosteroid preparation
- (2008) C. Sohy et al. ALLERGY
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now